Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scholefield, J H
Right arrow Articles by Hardcastle, J D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scholefield, J H
Right arrow Articles by Hardcastle, J D
Gut 2002;50:840-844
© 2002 by Gut


CANCER

Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial

J H Scholefield1, S Moss2, F Sufi2, C M Mangham1, J D Hardcastle1

1 Division of GI Surgery, University Hospital, Nottingham NG7 2UH, UK
2 Cancer Screening Evaluation Unit, Sutton, Surrey SM2 5NG, UK

Correspondence to:
Correspondence to:
Professor J H Scholefield, Division of GI Surgery, University Hospital, Nottingham NG72 UH, UK;
john.scholefield{at}nottingham.ac.uk

Background: Three large randomised trials have shown that screening for colorectal cancer using faecal occult blood (FOB) tests can reduce the mortality from this disease. Two national pilot studies have recently been launched in the UK to investigate the feasibility of population screening for colorectal cancer in the National Health Service. The largest of the randomised trials was conducted in Nottingham and randomised 152 850 individuals between the ages of 45 and 74 years to receive biennial Haemoccult (FOB) test kit (intervention group) or to a control group.

Aims: We have compared the mortality in the intervention group compared with the control group.

Methods: The 152 850 randomised individuals were followed up through local health records and central flagging (Office for National Statistics) over a median follow up period of 11 years.

Results: At a median follow up of 11 years there was a 13% reduction in colorectal cancer mortality (95% confidence interval 3–22%) in the intervention group despite an uptake at first invitation of only approximately 50%. The mortality reduction for those accepting screening was 27%. The reduction in mortality was independent of sex and site of tumour. There was no significant difference in mortality from causes other than colorectal cancer between the intervention and control groups.

Conclusions: Although the reduction in colorectal cancer mortality was sustained, further follow up of this population is required to determine whether a significant reduction in the incidence of colorectal cancer will be achieved.


Keywords: faecal occult blood test; colorectal cancer; screening; mortality

Abbreviations: CRC, colorectal cancer; FOB, faecal occult blood; RR, relative risk; ONS, Office for National Statistics




This article has been cited by other articles:


Home page
BMJHome page
N. Malila, T. Oivanen, O. Malminiemi, and M. Hakama
Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design
BMJ, November 20, 2008; 337(nov20_2): a2261 - a2261.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
D. Papamichael, R. Audisio, J.-C. Horiot, B. Glimelius, J. Sastre, E. Mitry, E. Van Cutsem, M. Gosney, C.-H. Kohne, and M. Aapro
Treatment of the elderly colorectal cancer patient: SIOG expert recommendations
Ann. Onc., October 15, 2008; (2008) mdn532v1.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
S J Goodyear, E Leung, A Menon, S Pedamallu, N Williams, and L S Wong
The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire
Gut, February 1, 2008; 57(2): 218 - 222.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. B. Knudsen, P. M. McMahon, and G. S. Gazelle
Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs
J. Clin. Oncol., January 10, 2007; 25(2): 203 - 208.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
Population screening for colorectal cancer
DTB, September 1, 2006; 44(9): 65 - 68.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
E. T. Hawk and B. Levin
Colorectal Cancer Prevention
J. Clin. Oncol., January 10, 2005; 23(2): 378 - 391.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
J. M. E. Walsh and J. P. Terdiman
Colorectal Cancer Screening: Scientific Review
JAMA, March 12, 2003; 289(10): 1288 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1.
[Full Text] [PDF]


Home page
JWatch GastroenterologyHome page
The Nottingham FOBT Trial: Results of Longer Follow-up
Journal Watch Gastroenterology, July 2, 2002; 2002(702): 2 - 2.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology